版权归中华医学会所有。
未经授权,不得转载、摘编本刊文章。
引用本文:简喜超, 简扬, 邓呈亮. 2025版《中国糖尿病足防治实践指南》解读[J]. 中华医学美学美容杂志, 2026, 32(2): 99-103. DOI: 10.3760/cma.j.cn114657-20251215-00266.
通信作者:邓呈亮,Email:该Email地址已收到反垃圾邮件插件保护。要显示它您需要在浏览器中启用JavaScript。
Athina Stamati1 · Athanasios Christoforidis2
Received: 7 October 2024 / Accepted: 31 December 2024 / Published online: 10 January 2025 © The Author(s) 2025
Abstract
Aims To assess the efficacy and safety of automated insulin delivery (AID) systems compared to standard care in managing glycaemic control during pregnancy in women with Type 1 Diabetes Mellitus (T1DM).
Methods We searched MEDLINE, Cochrane Library, registries and conference abstracts up to June 2024 for randomized controlled trials (RCTs) and observational studies comparing AID to standard care in pregnant women with T1DM. We con-ducted random effects meta-analyses for % of 24-h time in range of 63–140 mg/dL (TIR), time in hyperglycaemia (>140 mg/ dl and>180 mg/dL), hypoglycaemia (<63 mg/dl and<54 mg/dL), total insulin dose (units/kg/day), glycemic variability (%), changes in HbA1c (%), maternal and fetal outcomes.
Results Thirteen studies (450 participants) were included. AID significantly increased TIR (Mean difference, MD 7.01%, 95% CI 3.72–10.30) and reduced time in hyperglycaemia>140 mg/dL and>180 mg/dL (MD – 5.09%, 95% CI – 9.41 to – 0.78 and MD – 2.44%, 95% CI – 4.69 to – 0.20, respectively). Additionally, glycaemic variability was significantly reduced (MD – 1.66%, 95% CI – 2.73 to – 0.58). Other outcomes did not differ significantly.
Conclusion AID systems effectively improve glycaemic control during pregnancy in women with T1DM by increasing TIR and reducing hyperglycaemia without any observed adverse short-term effects on maternal and fetal outcomes.
Keywords Automated insulin delivery · Pregnancy · Type 1 diabetes mellitus · Systematic review · Meta-analysis
Abstract: Plasma derivatives have extensive applications in the field of regenerative medicine. Platelet-rich plasma (PRP) is a blood component acquired through centrifugation and can be administered through periwound injection or direct application to the wound bed area. PRP aids in shifting the healing process from chronic to acute, fostering regeneration in traumatic and surgical wounds. Here, we present seven cases of challenging wounds in paediatric patients that were treated using PRP at our institution.
Biagio Nicolosi,
Wound Clinical Nurse Specialist, Burn Center, Health Professions Department, AOU Meyer Children’s Hospital IRCCS, Florence, Italy
Virginia Carletti,
School of Paediatric and Neonatal Surgery, AOUMeyer Children’s Hospital IRCCS, Florence, Italy
Martina Certini,
School of Paediatric and Neonatal Surgery, AOU Meyer Children’s Hospital IRCCS, Florence, Italy
Giorgia Libro,
Emiliano Ambretti,
School of Paediatrics, University of Siena, Siena, Italy
Paola Pavan,
Department of Immunohematology and Transfusion Medicine, AOU Meyer Children’s Hospital IRCCS, Florence, Italy
Flavio Facchini,
Department of Paediatric and Neonatal Surgery, AOU Meyer Children’s Hospital IRCCS, Florence, Italy
Antonino Morabito, Department of Paediatric and Neonatal Surgery, AOU Meyer Children’s Hospital IRCCS, Florence, Italy; Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence; Florence, Italy; School of Health and Society, University of Salford, Salford, UK
Valentina Granai
Pediatric intensive care unit Nurse, Meyer Children’s hospital IRCCS, Florence, Italy
Key words
Abstract: Chronic, hard-to-heal wounds affect millions of people worldwide, representing a burden for healthcare systems, society, and patients. The following case series describes the use of an advanced therapy (oxygen wound therapy). The results of two patients with chronic wounds suggests this that oxygen therapy can improve outcomes, while allowing self-care by the patient and leading to increased adherence to the treatment plan.
Aisling Roberts, Surgical ACP, DrEd (year 3), Mscadvanced practice in skin integrity, Bsc, Pgc in chronic oedema. Great western hospital
Adherence Chronic wounds Oxygen therapy Self-care
Declaration of interest
The authors have no conflicting interests. This was a product in current use in the Leg Ulcer Clinic. Both patients consented to the use of their treatment and images for this publication.
Abstract: Kaposi’s sarcoma caused by Kaposi’s sarcoma-associated virus, is a rare malignancy in the general population with unique features. However, clinical presentation on the feet can mimic a diabetic foot ulcer. Here we describe the case of a 63-year-old male with type 2 diabetes, who presented with a lesion on the left 4th toe. Left foot radiograph in lateral and dorsoplantar views were normal. Full skin examination identified lesions with a similar morphology on the forearms. A HIV antigen/antibody test was negative, histology showed CD31 positive spindle cells and the presence of Kaposi’s sarcoma-associated virus confirming the diagnosis of Kaposi’s sarcoma. Kaposi’s sarcoma-associated virus’ lytic cycle can be triggered by the immunosuppressive state caused by tissue’s chronic exposure to a hyperglycaemic environment. A thorough general examination to identify lesions elsewhere in the body can help to identify the systemic nature of the disease. Pedal lesions in patients with diabetes with an atypical presentation that are refractory to standard treatment should prompt early histological examination. Early diagnosis and intervention can improve the chances of remission.
Farishta Khan,
Norfolk and Norwich University Hospitals NHS Foundation Trust
Dijon Millette,
Mersey and West Lancashire Teaching Hospitals NHS Trust
Roshan Siddique,
St George’s University of London
Haroon Siddique,
Russell Hall Hospital, Dudley Group NHS Trust
This article is based on a presentation by Professor Steven Jeffery at the annual Wounds UK conference in Harrogate, on 7 November 2023. Professor Jeffery presented clinical studies on how a bioengineered wound therapy with a porcine urinary bladder matrix (UBM) may facilitate healing of chronic wounds.
Steven LA Jeffery
Medical Director Pioneer Wound Telehealth and Professor of Wound Study, Birmingham City University
John McRobert
Clinical Research Director, Pioneer Wound Telehealth
This meeting report has been funded by an educational grant from Integra
伤口世界平台生态圈,以“关爱人间所有伤口患者”为愿景,连接、整合和拓展线上和线下的管理慢性伤口的资源,倡导远程、就近和居家管理慢性伤口,解决伤口专家的碎片化时间的价值创造、诊疗经验的裂变复制、和患者的就近、居家和低成本管理慢性伤口的问题。
2019广东省医疗行业协会伤口管理分会年会
扫一扫了解详情:
任何关于疾病的建议都不能替代执业医师的面对面诊断。所有门诊时间仅供参考,最终以医院当日公布为准。
网友、医生言论仅代表其个人观点,不代表本站同意其说法,请谨慎参阅,本站不承担由此引起的法律责任。